Articles published by MarketBeat
Inventiva Q2 Earnings Call Highlights ↗
September 28, 2026
Via MarketBeat
Tickers
FDX
The Nasdaq Nears a Major Breakout: 5 Tech ETFs to Play the Move ↗
September 28, 2026
Analyst Rating Boosts May Signal More Upside for These 3 Stocks ↗
September 28, 2026
Kandi Technologies Group Q2 Earnings Call Highlights ↗
September 28, 2026
Fertilizer Prices Keep Climbing: 3 Stocks Still Trading at a Discount ↗
September 28, 2026
Why 3 Struggling Stocks Are Suddenly Spending Big on Buybacks ↗
September 28, 2026
Via MarketBeat
3 Niche Growth Stocks With an Edge Their Rivals Can’t Ignore ↗
September 28, 2026
3 Dividend Stocks With Higher Yields and Room for More Payout Growth ↗
September 28, 2026
Cullinan Therapeutics Eyes December Data Catalyst for CLN-978 and CLN-049 ↗
September 28, 2026
Via MarketBeat
Tickers
CGEM
Oportun Financial Eyes Stronger 2026 as Credit Quality, Profits Improve ↗
September 28, 2026
Via MarketBeat
Tullow Oil H1 Earnings Call Highlights ↗
September 28, 2026
Via MarketBeat
Topics
Earnings
Cue Biopharma’s CUE-221 Hits Phase II Goals, Shows Durable CSU Response ↗
September 28, 2026
Via MarketBeat
HighPeak Energy Targets Stable Output, Lower Costs and Debt Reduction ↗
September 28, 2026
Via MarketBeat
Tennant Targets $250M in Robotics Sales as ERP Recovery Gains Traction ↗
September 27, 2026
Via MarketBeat
Tickers
TNC
AZZ Raises Outlook as Infrastructure, Data Centers and Acquisitions Drive Growth ↗
September 27, 2026
Via MarketBeat
Tickers
AZZ
Equillium Eyes Q4 Phase I Start for Ulcerative Colitis Drug EQ504 ↗
September 27, 2026
Via MarketBeat
Tickers
CMCO
Tamboran Resources Q4 Earnings Call Highlights ↗
September 27, 2026
ThredUp Posts Record Q2, Navigates More Price-Sensitive Shoppers ↗
September 27, 2026
Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance ↗
September 27, 2026
Via MarketBeat
Tickers
NKTX
PRA Group Highlights Strong NPL Supply, Cost Cuts and $150M Buyback Plan ↗
September 27, 2026
Via MarketBeat
Tickers
PRAA
Palisade Bio Advances PALI-2108 Into Phase II for Ulcerative Colitis and Crohn’s ↗
September 27, 2026
Via MarketBeat
Tickers
PALI
Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes ↗
September 27, 2026
Xenon Files Azetukalner NDA as It Pauses Psychiatry Trials for Tolerability Review ↗
September 27, 2026
Via MarketBeat
Tickers
XENE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
